Jupiter to Earth: CRP promotes atherothrombosis
- PMID: 19183073
- PMCID: PMC2662775
- DOI: 10.1089/met.2009.EDI
Jupiter to Earth: CRP promotes atherothrombosis
Similar articles
-
The editor's roundtable: the JUPITER trial--initial results and clinical implications.Am J Cardiol. 2009 May 15;103(10):1417-25. doi: 10.1016/j.amjcard.2009.02.023. Am J Cardiol. 2009. PMID: 19427439 No abstract available.
-
Bringing JUPITER down to earth.Lancet. 2009 Apr 4;373(9670):1147-8. doi: 10.1016/S0140-6736(09)60448-7. Epub 2009 Mar 28. Lancet. 2009. PMID: 19329179 No abstract available.
-
Expanding the orbit of primary prevention--moving beyond JUPITER.N Engl J Med. 2008 Nov 20;359(21):2280-2. doi: 10.1056/NEJMe0808320. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997195 No abstract available.
-
Should we measure C-reactive protein on earth or just on JUPITER?Clin Cardiol. 2010 Apr;33(4):190-8. doi: 10.1002/clc.20681. Clin Cardiol. 2010. PMID: 20394038 Free PMC article. Review.
-
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Ther Adv Cardiovasc Dis. 2009. PMID: 19460829 Review.
Cited by
-
Inflammation, atherosclerosis, and psoriasis.Clin Rev Allergy Immunol. 2013 Apr;44(2):194-204. doi: 10.1007/s12016-012-8308-0. Clin Rev Allergy Immunol. 2013. PMID: 22359071 Review.
-
Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.Circulation. 2009 Nov 24;120(21):2088-94. doi: 10.1161/CIRCULATIONAHA.109.872796. Epub 2009 Nov 9. Circulation. 2009. PMID: 19901190 Free PMC article.
References
-
- Ridker PM, Danielson E, Fonseca F, Genest J, Gotto A, Kastelein J, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207. - PubMed
-
- Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med. 2005;2:29–36. - PubMed
-
- Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 2001;103:1933–1935. - PubMed
-
- Ridker RM, Cannon CP, Morrow D, Rifai N, Rose LM, Mc-Cabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20–28. - PubMed
-
- SEARCH Study Collaboration Group. Bowman L, Armitage J, Bulbulia R, Parish S, Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH): Characteristics of a randomized trial among 12064 myocardial infarction survivors. Am Heart J. 2007;154:815–823. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous